Literature DB >> 23416108

Regulation of DNA damage responses by ubiquitin and SUMO.

Stephen P Jackson1, Daniel Durocher.   

Abstract

Ubiquitylation and sumoylation, the covalent attachment of the polypeptides ubiquitin and SUMO, respectively, to target proteins, are pervasive mechanisms for controlling cellular functions. Here, we summarize the key steps and enzymes involved in ubiquitin and SUMO conjugation and provide an overview of how they are crucial for maintaining genome stability. Specifically, we review research that has revealed how ubiquitylation and sumoylation regulate and coordinate various pathways of DNA damage recognition, signaling, and repair at the biochemical, cellular, and whole-organism levels. In addition to providing key insights into the control and importance of DNA repair and associated processes, such work has established paradigms for regulatory control that are likely to extend to other cellular processes and that may provide opportunities for better understanding and treatment of human disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416108     DOI: 10.1016/j.molcel.2013.01.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  318 in total

1.  USP11 Is a Negative Regulator to γH2AX Ubiquitylation by RNF8/RNF168.

Authors:  Miao Yu; Kun Liu; Zebin Mao; Jianyuan Luo; Wei Gu; Wenhui Zhao
Journal:  J Biol Chem       Date:  2015-10-27       Impact factor: 5.157

Review 2.  Regulation of recombination and genomic maintenance.

Authors:  Wolf-Dietrich Heyer
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-03       Impact factor: 10.005

3.  Pli1(PIAS1) SUMO ligase protected by the nuclear pore-associated SUMO protease Ulp1SENP1/2.

Authors:  Minghua Nie; Michael N Boddy
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

4.  RNF138 joins the HR team.

Authors:  Simon Bekker-Jensen; Niels Mailand
Journal:  Nat Cell Biol       Date:  2015-11       Impact factor: 28.824

5.  ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase.

Authors:  Huibin Yang; Phillip L Palmbos; Lidong Wang; Evelyn H Kim; Gina M Ney; Chao Liu; Jayendra Prasad; David E Misek; Xiaochun Yu; Mats Ljungman; Diane M Simeone
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

6.  Double duty: ZMYND8 in the DNA damage response and cancer.

Authors:  Fade Gong; Kyle M Miller
Journal:  Cell Cycle       Date:  2018-03-19       Impact factor: 4.534

Review 7.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

Review 8.  DNA damage and tissue repair: What we can learn from planaria.

Authors:  Paul G Barghouth; Manish Thiruvalluvan; Melanie LeGro; Néstor J Oviedo
Journal:  Semin Cell Dev Biol       Date:  2018-05-03       Impact factor: 7.727

9.  DUB-resistant ubiquitin to survey ubiquitination switches in mammalian cells.

Authors:  Miklós Békés; Keiji Okamoto; Sarah B Crist; Mathew J Jones; Jessica R Chapman; Bradley B Brasher; Francesco D Melandri; Beatrix M Ueberheide; Eros Lazzerini Denchi; Tony T Huang
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

10.  Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.

Authors:  Sahra Bodo; Cécile Campagne; Tin Htwe Thin; Daniel S Higginson; H Alberto Vargas; Guoqiang Hua; John D Fuller; Ellen Ackerstaff; James Russell; Zhigang Zhang; Stefan Klingler; HyungJoon Cho; Matthew G Kaag; Yousef Mazaheri; Andreas Rimner; Katia Manova-Todorova; Boris Epel; Joan Zatcky; Cristian R Cleary; Shyam S Rao; Yoshiya Yamada; Michael J Zelefsky; Howard J Halpern; Jason A Koutcher; Carlos Cordon-Cardo; Carlo Greco; Adriana Haimovitz-Friedman; Evis Sala; Simon N Powell; Richard Kolesnick; Zvi Fuks
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.